Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
3
×
biotech
3
×
life sciences
national blog main
national top stories
new york top stories
boston blog main
boston top stories
clinical trials
europe top stories
fda
national
new york blog main
novartis
ptc therapeutics
san francisco top stories
startups
venture capital
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
antisense oligonucleotide
asklepios biopharmaceutical
benzodiazepines
billy dunn
bioeurope
biomarin pharmaceutical
blackstone group
blackstone life sciences
boston
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer
cara therapeutics
columbia university
david goldstein
deerfield management
What
new
3
×
fda
medicines
activity
aims
approvals
approved
atrophy
backed
bio
biogen
cause
ceo
clamped
covid
daily
delays
developing
drug
drugs
economic
epilepsy
evrysdi
fast
friday
genes
genetic
green
home
including
intended
ipo
isn’t
lights
links
liquid
lot
marcio
medicine
muscular
Language
unset
3
×
Current search:
biogen
×
new
×
biotech
×
unset
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More